Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × Cetuximab × Clear all

NCT00063401 2010-04-08

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms